Deciphera Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Deciphera Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Deciphera Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $10.2M, a 18.7% decline year-over-year.
  • Deciphera Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $48.3M, a 3.84% decline year-over-year.
  • Deciphera Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $50.6M, a 2.58% decline from 2022.
  • Deciphera Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $51.9M, a 12.7% increase from 2021.
  • Deciphera Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $46.1M, a 24.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $50.6M -$1.34M -2.58% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-07
2022 $51.9M +$5.86M +12.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-07
2021 $46.1M +$8.94M +24.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-07
2020 $37.1M +$16.7M +82% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-07
2019 $20.4M +$10.7M +111% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-08
2018 $9.69M +$4.82M +99.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-09
2017 $4.87M +$3.38M +227% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 $1.49M -$1.07M -41.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $2.56M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.